Contact this trialFirst, we need to learn more about you.
Nonsteroidal Anti-inflammatory Drug (NSAID)
DFMO + Celecoxib + Cyclophosphamide + Topotecan for Neuroblastoma
Recruiting3 awardsPhase 1
Boston, Massachusetts
This trial will study the effects of combining DFMO with celecoxib, cyclophosphamide, and topotecan. The goal is to find the highest dosage of DFMO that can be given without causing severe side effects, and to study the side effects seen at different dose levels.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.